window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Therapeutic Areas

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Breye Therapeutics reports Phase 1b data for oral danegaptide in non-proliferative diabetic retinopathy

    Breye Therapeutics has presented Phase 1b clinical data for its [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Evogene licenses microbiome cancer therapy BMC128 to Shanghai Lishan Biopharmaceuticals

    Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    NeoVac reports Phase 1 and Phase 2 data for NeomiVac mRNA LNP covid-19 vaccine

    NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Newron publishes data showing clinically meaningful benefits of evenamide in treatment-resistant schizophrenia

    Newron Pharmaceuticals has published peer-reviewed clinical data demonstrating that evenamide, [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Therapeutic Areas

    Rainwater Charitable Foundation announces 2026 Rainwater Prize winners for tauopathy research

    The Rainwater Charitable Foundation (RCF) has announced the recipients of [...]

    May 5, 2026
  • Pharmaceuticals and therapeutics,Therapeutic Areas

    Nordic Pharma launches Lacrifill canalicular gel across Europe

    nordic-pharma-lacrifill-europe-launch Nordic Pharma has launched Lacrifill, a canalicular gel therapy [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    SpotitEarly partners with Fox Chase Cancer Center to advance breath-based cancer detection trials

    SpotitEarly has entered into a strategic research partnership with Fox [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Cereno Scientific broadens CS014 development focus to pulmonary hypertension linked to interstitial lung disease

    Cereno Scientific has broadened the clinical development focus of its [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Quest Diagnostics launches flow cytometry MRD blood test for myeloma to support ultrasensitive monitoring

    Quest Diagnostics has introduced a new blood-based test for measurable [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Levicept appoints James Sandy as chief development officer to advance LEVI-04 for osteoarthritis

    Levicept has strengthened its executive team with the appointment of [...]

    May 5, 2026
Previous101112Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration
    Categories: Advanced Therapies, Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
  • Allucent adds strategy leaders to expand therapeutic expertise
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform
    Categories: Advanced Therapies, Biotech & Pharma Business, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top